13,14-Dihydro-15-keto-PGE1
Selected Variant
HY-137591-01
Size: 1 mg
13,14-Dihydro-15-keto-PGE1 is an inactive metabolite of PGE1. 13, 14-Dihydro-15-Keto-pGE1 inhibited platelet aggregation in ADP-induced human isolated platelet-rich plasma with IC50 14.8 μg/mL[1].
Product Specifications
CAS Number
5094-14-4
UNSPSC
12352211
Target
Drug Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology
Assay Protocol
https://www.medchemexpress.com/13-14-dihydro-15-keto-pge1.html
Solubility
10 mM in DMSO
Smiles
OC(CCCCCC[C@@H]1[C@H]([C@@H](CC1=O)O)CCC(CCCCC)=O)=O
Molecular Formula
C20H34O5
Molecular Weight
354.48
References & Citations
[1]Katzenschlager R, et al. Synergism between PGE1-metabolites (13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregation. Prostaglandins Leukot Essent Fatty Acids. 1992 Mar;45 (3) :207-10.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog